Search research articles
Contact Us
Filters
Showing results (91-100 of 336) with videos related to
Page
of 34
Sort By:
Therapeutic Advances in Urology
|
July 22, 2021
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, et al.
Oncology Research
|
January 8, 2026
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review
Giacomo Iovane, Luca Traman, Michele Maffezzoli, et al.
Critical Reviews in Oncology/Hematology
|
May 22, 2019
State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough
Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, et al.
Critical Reviews in Oncology/Hematology
|
February 5, 2021
Outcome of patients with advanced upper tract urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Melissa Bersanelli, Sebastiano Buti, Patrizia Giannatempo, et al.
Tumori
|
September 23, 2015
Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder
Melissa Bersanelli, Paola Bini, Enrico Rabaiotti, et al.
Minerva Urology and Nephrology
|
May 11, 2023
Prognostic models for patients with metastatic urothelial carcinoma: why use them?
Michele Maffezzoli, Davide Campobasso, Sara E Rebuzzi, et al.
Immunotherapy
|
November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis
Matteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
Therapeutic Advances in Urology
|
November 4, 2021
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
Carlo Cattrini, Carlo Messina, Chiara Airoldi, et al.
Anti-Cancer Drugs
|
April 5, 2013
Chemotherapy in metastatic renal cell carcinoma today? A systematic review
Sebastiano Buti, Melissa Bersanelli, Angelica Sikokis, et al.
World Journal of Radiology
|
October 11, 2021
Review on radiological evolution of COVID-19 pneumonia using computed tomography
Chiara Casartelli, Fabiana Perrone, Maurizio Balbi, et al.
Page
of 34
Search research articles
Search
Showing results (91-100 of 336) with videos related to
Sort By:
Page
of 34
Therapeutic Advances in Urology
|
July 22, 2021
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, et al.
Oncology Research
|
January 8, 2026
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review
Giacomo Iovane, Luca Traman, Michele Maffezzoli, et al.
Critical Reviews in Oncology/Hematology
|
May 22, 2019
State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough
Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, et al.
Critical Reviews in Oncology/Hematology
|
February 5, 2021
Outcome of patients with advanced upper tract urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Melissa Bersanelli, Sebastiano Buti, Patrizia Giannatempo, et al.
Tumori
|
September 23, 2015
Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder
Melissa Bersanelli, Paola Bini, Enrico Rabaiotti, et al.
Minerva Urology and Nephrology
|
May 11, 2023
Prognostic models for patients with metastatic urothelial carcinoma: why use them?
Michele Maffezzoli, Davide Campobasso, Sara E Rebuzzi, et al.
Immunotherapy
|
November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis
Matteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
Therapeutic Advances in Urology
|
November 4, 2021
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
Carlo Cattrini, Carlo Messina, Chiara Airoldi, et al.
Anti-Cancer Drugs
|
April 5, 2013
Chemotherapy in metastatic renal cell carcinoma today? A systematic review
Sebastiano Buti, Melissa Bersanelli, Angelica Sikokis, et al.
World Journal of Radiology
|
October 11, 2021
Review on radiological evolution of COVID-19 pneumonia using computed tomography
Chiara Casartelli, Fabiana Perrone, Maurizio Balbi, et al.
Page
of 34